Boehringer Ingelheim 보도자료 - 뉴스와이어

Boehringer Ingelheim 보도자료

Boehringer Ingelheim 보도자료

Photo: Business Wire

Photo: Business Wire: 2016년 6월 27일 15:51; Boehringer Ingelheim

Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalized pustular psoriasis

Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalized pustular psoriasis: 2021년 12월 23일 16:30; Boehringer Ingelheim

About Generalized Pustular Psoriasis (Graphic: Business Wire)

About Generalized Pustular Psoriasis (Graphic: Business Wire): 2023년 7월 4일 16:25; Boehringer Ingelheim

The IL-36 pathway and generalized pustular psoriasis (Graphic: Business Wire)

The IL-36 pathway and generalized pustular psoriasis (Graphic: Business Wire): 2023년 7월 4일 16:25; Boehringer Ingelheim

메뉴 닫기